Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluska

Showing results (291-300 of 366) with videos related to

Pageof 37
Sort By:
Journal of the American Chemical Society|December 11, 2007
Rapid bioenabled formation of ferroelectric BaTiO3 at room temperature from an aqueous salt solution at near neutral pHGul Ahmad, Matthew B Dickerson, Ye Cai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelC Sessa, D Tosi, L Viganò, et al.
Transplantation|October 29, 2013
Uremic toxin development in living kidney donors: a longitudinal studyMegan Rossi, Katrina L Campbell, David W Johnson, et al.
Gynecologic Oncology|November 4, 2011
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinomaAndrea E Wahner Hendrickson, Ann L Oberg, Gretchen Glaser, et al.
BMC Nephrology|October 4, 2011
Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort studyCarolyn L van Eps, Leanne Jeffriess, Brian Haluska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
A multicenter, first-in-pediatrics, phase 1, pharmacokinetic and pharmacodynamic study of ridaforolimus in patients with refractory solid tumorsLia Gore, Tanya M Trippett, Howard M Katzenstein, et al.
Nature Structural & Molecular Biology|June 18, 2024
Cryo-EM structures of Smc5/6 in multiple states reveal its assembly and functional mechanismsQian Li, Jun Zhang, Cory Haluska, et al.
Cancer Chemotherapy and Pharmacology|January 7, 2014
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignanciesDaruka Mahadevan, Gregory Ryan Sutton, Rafael Arteta-Bulos, et al.
Cancer Research|October 1, 2009
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitroAndrea E Wahner Hendrickson, Paul Haluska, Paula A Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumorsPaul Haluska, Heather M Shaw, Gretchen N Batzel, et al.
Pageof 37

Showing results (291-300 of 366) with videos related to

Sort By:
Pageof 37
Journal of the American Chemical Society|December 11, 2007
Rapid bioenabled formation of ferroelectric BaTiO3 at room temperature from an aqueous salt solution at near neutral pHGul Ahmad, Matthew B Dickerson, Ye Cai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelC Sessa, D Tosi, L Viganò, et al.
Transplantation|October 29, 2013
Uremic toxin development in living kidney donors: a longitudinal studyMegan Rossi, Katrina L Campbell, David W Johnson, et al.
Gynecologic Oncology|November 4, 2011
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinomaAndrea E Wahner Hendrickson, Ann L Oberg, Gretchen Glaser, et al.
BMC Nephrology|October 4, 2011
Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort studyCarolyn L van Eps, Leanne Jeffriess, Brian Haluska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
A multicenter, first-in-pediatrics, phase 1, pharmacokinetic and pharmacodynamic study of ridaforolimus in patients with refractory solid tumorsLia Gore, Tanya M Trippett, Howard M Katzenstein, et al.
Nature Structural & Molecular Biology|June 18, 2024
Cryo-EM structures of Smc5/6 in multiple states reveal its assembly and functional mechanismsQian Li, Jun Zhang, Cory Haluska, et al.
Cancer Chemotherapy and Pharmacology|January 7, 2014
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignanciesDaruka Mahadevan, Gregory Ryan Sutton, Rafael Arteta-Bulos, et al.
Cancer Research|October 1, 2009
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitroAndrea E Wahner Hendrickson, Paul Haluska, Paula A Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumorsPaul Haluska, Heather M Shaw, Gretchen N Batzel, et al.
Pageof 37